Regencell Bioscience Holdings RGC
NASDAQ RGC
$5.45 -0.36 (-6.28%)
At close: Aug 20, 2026 · 3:06 PM UTC

Regencell Bioscience Holdings (RGC) Enterprise Value Growth (1y) (2021 - 2025)

Regencell Bioscience Holdings (RGC) Enterprise Value Growth (1y) (2021 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.86 Bn 42.90 Bn -
2 Teva Pharmaceutical Industries 43.19 Bn 39.54 Bn 2.15 Bn
3 Zoetis 31.46 Bn 29.79 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.57 Bn 22.77 Bn 5.10 Bn
5 United Therapeutics 22.15 Bn 19.49 Bn 683.80 Mn
6 Viatris 18.75 Bn 17.86 Bn 1.46 Bn
7 Neurocrine Biosciences 15.50 Bn 15.11 Bn 935.80 Mn
8 Elanco Animal Health 11.71 Bn 11.18 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.12 Bn 9.95 Bn -
10 Regencell Bioscience Holdings 2.71 Bn 2.71 Bn -

Historic Data

Download Data
DateValue
Jun 30, 2025 68.88%
Jun 30, 2024 31.40%
Jun 30, 2023 29.24%
Jun 30, 2022 -27,506.10%
Jun 30, 2021 84.65%